天坛生物：公司控股股东拟将持有的约1880万股股份无偿划转至中国生物

Core Viewpoint - Tian Tan Bio announced that its controlling shareholder, China National Biological Group Corporation, will transfer 18,802,366 shares (0.95% of total shares) to itself without compensation, resulting in China National holding 46.59% of the total shares post-transfer [1] Summary by Sections - Share Transfer Details - The transfer involves 18,802,366 shares from Beijing Biological Products Research Institute to China National [1] - After the transfer, China National will directly hold 921,302,854 shares, representing 46.59% of the total share capital [1] - Ownership Structure Post-Transfer - Beijing Biological Products Research Institute will no longer hold any shares in the company [1] - China National and its concerted parties will collectively hold 991,120,289 shares, maintaining a total ownership of 50.12% [1]